New Albany selected as home for Ohio’s $30 million biomanufacturing talent push
With over $500B in domestic biomanufacturing investment at stake, Ohio is moving to bridge the "skills gap" that often stalls major pharma expansions. By anchoring this hub in New Albany’s existing biotech cluster, the state aims to turn a local success story into a 88-county talent engine.
Ohio is placing a $30 million bet on the future of drug manufacturing, and it just found its anchor.
The Ohio Life Sciences Association (OLS) and JobsOhio announced this week that the New Albany International Business Park will serve as the inaugural site for the Ohio Life Science Training Center. The facility is the centerpiece of a statewide biomanufacturing workforce initiative designed to bridge the gap between Ohio’s rapid industrial growth and the specialized talent required to sustain it.
The Big Picture
Global competition for life sciences investment is fierce, with over $500 billion in domestic biomanufacturing opportunities currently on the table. By establishing a dedicated training hub, Ohio aims to provide a "workforce-ready" pipeline that makes the state an irresistible destination for pharmaceutical giants.
"Ohio is making a foundational investment in its workforce to capture an unprecedented opportunity in biomanufacturing," JobsOhio President and CEO J.P. Nauseef said of the news.
By the Numbers
- $30 Million: The total investment from JobsOhio over five years to build the training ecosystem.
- $5 Million: A local commitment from the City of New Albany over five years to support the center’s development.
- 64,000: The number of Ohioans currently employed in the life sciences industry statewide.
- 3,300: New Ohio-based jobs created in the sector over the last five years.
The Strategy
Operated by OLS, the center will not just be a local asset but the "hub" in a hub-and-spoke model. The curriculum—developed in direct partnership with industry leaders—will be standardized and pushed out to a network of community colleges, technical schools, and universities across the state.
"By bringing partners together around shared priorities, we’re strengthening today’s industry and creating new opportunities for growth across the state," said Eddie Pauline, President and CEO of OLS.
Inside the Lab
To move beyond traditional classroom learning, the facility will feature:
- Simulated Clean Rooms: Allowing students to practice in sterile environments essential for drug production.
- Hands-on Training: Focusing on Current Good Manufacturing Practices (cGMP), lab skills, and manufacturing foundations.
- Entry-Level Focus: Specifically targeting operator and technician roles, which are the highest-demand positions for scaling biotech firms.
Why New Albany?
The location choice is strategic. The New Albany International Business Park is already home to a burgeoning life sciences cluster, including Amgen’s new 300,000-square-foot high-tech facility and companies like American Regent and Pharmavite. Placing the training center in their backyard allows for a feedback loop between employers and educators.
What’s next
While a specific opening date has not yet been set, the selection of New Albany marks the official transition from the "Biomanufacturing Workforce Initiative" announced in late 2025 to a physical reality. In the coming months, OLS and JobsOhio are expected to name additional regional "spoke" partners to ensure the training reaches all 88 Ohio counties.
